Luminai Raises USD 38 Mn in Series B Funding
The Series B funding round was led by Peak XV Partners, with participation from Define Ventures, General Catalyst, and Y Combinator.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
Luminai, a San Francisco-based company focused on AI-driven enterprise automation for healthcare operations, has raised USD 38 million in a Series B funding round led by Peak XV Partners, with participation from Define Ventures, General Catalyst, and Y Combinator.
The latest funding brings the company’s total capital raised to USD 60 million.
Founded in 2020 by CEO Kesava Kirupa Dinakaran, Luminai develops robotic process automation software that enables organisations to automate repetitive, multi-step workflows. Its platform simulates human actions across digital systems to improve efficiency in sectors including healthcare, finance, and customer service.
The company’s technology combines healthcare-trained AI models, a configurable workflow engine, and human-in-the-loop validation to manage administrative and operational processes. It also supports flexible deployment options such as on-premises and cloud environments.
Luminai said the new funds will be used to expand product capabilities, grow its engineering and deployment teams, and support increasing enterprise demand for scalable automation solutions.
Luminai, a San Francisco-based company focused on AI-driven enterprise automation for healthcare operations, has raised USD 38 million in a Series B funding round led by Peak XV Partners, with participation from Define Ventures, General Catalyst, and Y Combinator.
The latest funding brings the company’s total capital raised to USD 60 million.
Founded in 2020 by CEO Kesava Kirupa Dinakaran, Luminai develops robotic process automation software that enables organisations to automate repetitive, multi-step workflows. Its platform simulates human actions across digital systems to improve efficiency in sectors including healthcare, finance, and customer service.
The company’s technology combines healthcare-trained AI models, a configurable workflow engine, and human-in-the-loop validation to manage administrative and operational processes. It also supports flexible deployment options such as on-premises and cloud environments.
Luminai said the new funds will be used to expand product capabilities, grow its engineering and deployment teams, and support increasing enterprise demand for scalable automation solutions.
